Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07803328 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Perioperative Role Of Vascular Endothelial Growth Factor In Cardiac Surgery-associated Acute Kidney Injury

Study acronym: PROVE-AKI
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this prospective observational study is to find out whether the protein vascular endothelial growth factor (VEGF) measured in blood and urine can predict which patients will develop acute kidney injury (AKI) after heart-type surgery that uses a heart-lung machine (cardiopulmonary bypass).
Trial Details
NCT Number NCT07803328
Lead Sponsor Universität Münster
Conditions
(from sponsor)		 Acute Kidney Injury, Cardiac Surgery Associated - Acute Kidney Injury
Related terms Acute Kidney Injury
Enrollment 220 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov